GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
This Quarter Return
-6.77%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$287M
AUM Growth
+$287M
Cap. Flow
-$57.4M
Cap. Flow %
-19.96%
Top 10 Hldgs %
40.75%
Holding
78
New
11
Increased
22
Reduced
19
Closed
17

Top Buys

1
ASND icon
Ascendis Pharma
ASND
$11.8M
2
BHVN icon
Biohaven
BHVN
$7.12M
3
RZLT icon
Rezolute
RZLT
$6.11M
4
CGON icon
CG Oncology
CGON
$5.84M
5
CRBP icon
Corbus Pharmaceuticals
CRBP
$5.34M

Top Sells

1
SRPT icon
Sarepta Therapeutics
SRPT
$11.1M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
$9.11M
3
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
$6.65M
4
TGTX icon
TG Therapeutics
TGTX
$5.78M
5
INSM icon
Insmed
INSM
$5.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SGMT icon
51
Sagimet Biosciences
SGMT
$239M
$770K 0.24%
225,000
– –
ITCI
52
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$685K 0.21%
+10,000
New +$685K
MGNX icon
53
MacroGenics
MGNX
$121M
$638K 0.2%
+150,000
New +$638K
PMVP icon
54
PMV Pharmaceuticals
PMVP
$82.1M
$608K 0.19%
375,000
-300,000
-44% -$486K
PTCT icon
55
PTC Therapeutics
PTCT
$4.41B
$581K 0.18%
+19,000
New +$581K
RVNC
56
DELISTED
Revance Therapeutics, Inc.
RVNC
$578K 0.18%
225,000
-225,000
-50% -$578K
NTLA icon
57
Intellia Therapeutics
NTLA
$1.26B
$560K 0.18%
25,000
– –
ANTX icon
58
AN2 Therapeutics
ANTX
$35.3M
$472K 0.15%
219,331
– –
CTMX icon
59
CytomX Therapeutics
CTMX
$350M
$366K 0.11%
300,000
-300,000
-50% -$366K
ALT icon
60
Altimmune
ALT
$325M
– –
-250,000
Closed -$2.55M
AQST icon
61
Aquestive Therapeutics
AQST
$478M
– –
-702,941
Closed -$2.99M
ATXS icon
62
Astria Therapeutics
ATXS
$394M
– –
-115,000
Closed -$1.62M
JBIO
63
Jade Biosciences, Inc. Common Stock
JBIO
$245M
– –
-225,000
Closed -$6.65M
COGT icon
64
Cogent Biosciences
COGT
$1.83B
– –
-450,000
Closed -$3.02M
EYPT icon
65
EyePoint Pharmaceuticals
EYPT
$827M
– –
-90,000
Closed -$1.86M
GERN icon
66
Geron
GERN
$893M
– –
-800,000
Closed -$2.64M
GPCR icon
67
Structure Therapeutics
GPCR
$1.14B
– –
-75,000
Closed -$3.21M
KALV icon
68
KalVista Pharmaceuticals
KALV
$713M
– –
-200,000
Closed -$2.37M
LRMR icon
69
Larimar Therapeutics
LRMR
$337M
– –
-210,603
Closed -$1.6M
MDGL icon
70
Madrigal Pharmaceuticals
MDGL
$9.7B
– –
-6,500
Closed -$1.74M
NTRA icon
71
Natera
NTRA
$23B
– –
-25,000
Closed -$2.29M
PTGX icon
72
Protagonist Therapeutics
PTGX
$3.62B
– –
-75,000
Closed -$2.17M
QURE icon
73
uniQure
QURE
$954M
– –
-165,000
Closed -$858K
RARE icon
74
Ultragenyx Pharmaceutical
RARE
$3.04B
– –
-20,000
Closed -$934K
RAPT icon
75
RAPT Therapeutics
RAPT
$187M
– –
0
– –
1 2
3
4